Oxidative stress and abdominal aortic aneurysm: Potential treatment targets

Clinical Science

Volumn 130, Issue 5, 2016, Pages 301-315

  Emeto, Theophilus I ^a   Moxon, Joseph V ^a   Au, Minnie ^a,b   Golledge, Jonathan ^a,b  

^a JAMES COOK UNIVERSITY   (Australia)

^b TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Abdominal aortic aneurysm; Animal models; Clinical trial; Oxidative stress; Pharmacotherapy

Indexed keywords

ANTIOXIDANT; CATALASE; HEME OXYGENASE; LIPOXYGENASE; NITRIC OXIDE SYNTHASE; PHENOL DERIVATIVE; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; THIOREDOXIN; XANTHINE OXIDASE;

ABDOMINAL AORTA ANEURYSM; APOPTOSIS; ARTICLE; DEGRADATION; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; ANIMAL; AORTIC ANEURYSM, ABDOMINAL; DISEASE MODEL; DRUG EFFECTS; EVIDENCE BASED MEDICINE; METABOLISM; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; PROCEDURES;

ANIMALS; ANTIOXIDANTS; AORTIC ANEURYSM, ABDOMINAL; DISEASE MODELS, ANIMAL; EVIDENCE-BASED MEDICINE; HUMANS; MOLECULAR TARGETED THERAPY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84958087905     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150547     Document Type: Article

References (153)

1. Emeto, T.I., Moxon, J.V., Biros, E., Rush, C.M., Clancy, P., Woodward, L., Moran, C.S., Jose, R.J., Nguyen, T., Walker, P.J. and Golledge, J. (2014) Urocortin 2 is associated with abdominal aortic aneurysm and mediates anti-proliferative effects on vascular smooth muscle cells via corticotrophin releasing factor receptor 2. Clin. Sci. 126, 517-527
2. Moxon, J.V., Parr, A., Emeto, T.I., Walker, P., Norman, P.E. and Golledge, J. (2010) Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects. Curr. Probl. Cardiol. 35, 512-548
3. Emeto, T.I., Seto, S.W. and Golledge, J. (2014) Targets for medical therapy to limit abdominal aortic aneurysm progression. Curr. Drug Targets 15, 860-873
4. Chaikof, E.L., Brewster, D.C., Dalman, R.L., Makaroun, M.S., Illig, K.A., Sicard, G.A., Timaran, C.H., Upchurch, Jr, G.R. and Veith, F.J. (2009) The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. J. Vasc. Surg. 50 (Suppl.), S2-S49
5. Khosla, S., Morris, D.R., Moxon, J.V., Walker, P.J., Gasser, T.C. and Golledge, J. (2014) Meta-analysis of peak wall stress in ruptured, symptomatic and intact abdominal aortic aneurysms. Br. J. Surg. 101, 1350-1357
6. Golledge, J. and Norman, P.E. (2009) Pathophysiology of abdominal aortic aneurysm relevant to improvements in patients' management. Curr. Opin. Cardiol. 24, 532-538
7. Tsutsui, H., Kinugawa, S. and Matsushima, S. (2011) Oxidative stress and heart failure. Am. J. Physiol. Heart. Circ. Physiol. 301, H2181-H2190
8. Vourliotakis, G. and Aivatidi, C. (2014) Oxidative stress and abdominal aortic aneurysms. In Systems Biology of Free Radicals and Antioxidants (Laher, I., ed.), pp. 1405-1422, Springer-Verlag, Berlin
9. Sawada, H., Hao, H., Naito, Y., Oboshi, M., Hirotani, S., Mitsuno, M., Miyamoto, Y., Hirota, S. and Masuyama, T. (2015) Aortic iron overload with oxidative stress and inflammation in human and murine abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 35, 1507-1514
10. Shang, T., Liu, Z. and Liu, C.J. (2014) Antioxidant vitamin C attenuates experimental abdominal aortic aneurysm development in an elastase-induced rat model. J. Surg. Res. 188, 316-325
11. Miller, Jr, F.J., Sharp, W.J., Fang, X., Oberley, L.W., Oberley, T.D. and Weintraub, N.L. (2002) Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler. Thromb. Vasc. Biol. 22, 560-565
12. Forstermann, U. (2008) Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat. Clin. Pract. Cardiovasc. Med. 5, 338-349
13. Forstermann, U. (2010) Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 459, 923-939
14. Lizarbe, T.R., Tarin, C., Gomez, M., Lavin, B., Aracil, E., Orte, L.M. and Zaragoza, C. (2009) Nitric oxide induces the progression of abdominal aortic aneurysms through the matrix metalloproteinase inducer EMMPRIN. Am. J. Pathol. 175, 1421-1430
15. Parodi, F.E., Mao, D., Ennis, T.L., Bartoli, M.A. and Thompson, R.W. (2005) Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB. J. Vasc. Surg. 41, 479-489
16. Costanzo, A., Moretti, F., Burgio, V.L., Bravi, C., Guido, F., Levrero, M. and Puri, P.L. (2003) Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J. Cell. Physiol. 195, 402-410
17. Li, Q. and Engelhardt, J.F. (2006) Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase. J. Biol. Chem. 281, 1495-1505
18. Xiong, W., Mactaggart, J., Knispel, R., Worth, J., Zhu, Z., Li, Y., Sun, Y., Baxter, B.T. and Johanning, J. (2009) Inhibition of reactive oxygen species attenuates aneurysm formation in a murine model. Atherosclerosis 202, 128-134
19. Kumar, B., Iqbal, M.A., Singh, R.K. and Bamezai, R. N. K. (2015) Resveratrol inhibits TIGAR to promote ROS induced apoptosis and autophagy. Biochimie 118, 26-35
20. Davies, K.J. (1999) The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 48, 41-47
21. Day, R.M., Suzuki, Y.J. and Fanburg, B.L. (2003) Regulation of glutathione by oxidative stress in bovine pulmonary artery endothelial cells. Antioxid. Redox Signal. 5, 699-704
22. Martinez-Pinna, R., Lindholt, J.S., Blanco-Colio, L.M., Dejouvencel, T., Madrigal-Matute, J., Ramos-Mozo, P., Vega de Ceniga, M., Michel, J.B., Egido, J., Meilhac, O. and Martin-Ventura, J.L. (2010) Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution. Atherosclerosis 212, 333-338
23. Gavrila, D., Li, W.G., McCormick, M.L., Thomas, M., Daugherty, A., Cassis, L.A., Miller, Jr, F.J., Oberley, L.W., Dellsperger, K.C. and Weintraub, N.L. (2005) Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25, 1671-1677
24. Nakahashi, T.K., Hoshina, K., Tsao, P.S., Sho, E., Sho, M., Karwowski, J.K., Yeh, C., Yang, R.B., Topper, J.N. and Dalman, R.L. (2002) Flow loading induces macrophage antioxidative gene expression in experimental aneurysms. Arterioscler Thromb. Vasc. Biol. 22, 2017-2022
25. Johanning, J.M., Franklin, D.P., Han, D.C., Carey, D.J. and Elmore, J.R. (2001) Inhibition of inducible nitric oxide synthase limits nitric oxide production and experimental aneurysm expansion. J. Vasc. Surg. 33, 579-586
26. Kaneko, H., Anzai, T., Morisawa, M., Kohno, T., Nagai, T., Anzai, A., Takahashi, T., Shimoda, M., Sasaki, A., Maekawa, Y. et al. (2011) Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization. Atherosclerosis 217, 350-357
27. Davis, V., Persidskaia, R., Baca-Regen, L., Itoh, Y., Nagase, H., Persidsky, Y., Ghorpade, A. and Baxter, B.T. (1998) Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 18, 1625-1633
28. Rizas, K.D., Ippagunta, N. and Tilson, III, M.D. (2009) Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm. Cardiol. Rev. 17, 201-210
29. Dubick, M.A., Hunter, G.C., Casey, S.M. and Keen, C.L. (1987) Aortic ascorbic acid, trace elements, and superoxide dismutase activity in human aneurysmal and occlusive disease. Proc. Soc. Exp. Biol. Med. 184, 138-143
30. Jung, O., Marklund, S.L., Geiger, H., Pedrazzini, T., Busse, R. and Brandes, R.P. (2003) Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ. Res. 93, 622-629
31. Jung, O., Marklund, S.L., Xia, N., Busse, R. and Brandes, R.P. (2007) Inactivation of extracellular superoxide dismutase contributes to the development of high-volume hypertension. Arterioscler. Thromb. Vasc. Biol. 27, 470-477
32. Dubick, M.A., Keen, C.L., Di Silvestro, R.A., Eskelson, C.D., Ireton, J. and Hunter, G.C. (1999) Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc. Soc. Exp. Biol. Med. 220, 39-45
33. Ayala, A., Munoz, M.F. and Arguelles, S. (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell Longev. 2014, 360438
34. Kinnunen, P.K., Kaarniranta, K. and Mahalka, A.K. (2012) Protein-oxidized phospholipid interactions in cellular signaling for cell death: from biophysics to clinical correlations. Biochim. Biophys. Acta 1818, 2446-2455
35. Iida, S., Chu, Y., Weiss, R.M., Kang, Y.M., Faraci, F.M. and Heistad, D.D. (2006) Vascular effects of a common gene variant of extracellular superoxide dismutase in heart failure. Am. J. Physiol. Heart Circ. Physiol. 291, H914-H920
36. Torzewski, M., Ochsenhirt, V., Kleschyov, A.L., Oelze, M., Daiber, A., Li, H., Rossmann, H., Tsimikas, S., Reifenberg, K., Cheng, F. et al. (2007) Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27, 850-857
37. Zhang, Y., Griendling, K.K., Dikalova, A., Owens, G.K. and Taylor, W.R. (2005) Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension 46, 732-737
38. Stocker, R. and Perrella, M.A. (2006) Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 114, 2178-2189
39. Jiang, F., Roberts, S.J., Datla, S.r. and Dusting, G.J. (2006) NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 48, 950-957
40. Aviram, M., Rosenblat, M., Bisgaier, C.L., Newton, R.S., Primo-Parmo, S.L. and La Du, B.N. (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101, 1581-1590
41. Yamawaki, H., Haendeler, J. and Berk, B.C. (2003) Thioredoxin: a key regulator of cardiovascular homeostasis. Circ. Res. 93, 1029-1033
42. Horke, S., Witte, I., Wilgenbus, P., Kruger, M., Strand, D. and Forstermann, U. (2007) Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 115, 2055-2064
43. Heller, R., Unbehaun, A., Schellenberg, B., Mayer, B., Werner-Felmayer, G. and Werner, E.R. (2001) L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J. Biol. Chem. 276, 40-47
44. Zhang, J., Schmidt, J., Ryschich, E., Mueller-Schilling, M., Schumacher, H. and Allenberg, J.R. (2003) Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury. J. Vasc. Surg. 38, 360-367
45. Sies, H. (1997) Oxidative stress: oxidants and antioxidants. Exp. Physiol. 82, 291-295
46. Yajima, N., Masuda, M., Miyazaki, M., Nakajima, N., Chien, S. and Shyy, J.Y. (2002) Oxidative stress is involved in the development of experimental abdominal aortic aneurysm: a study of the transcription profile with complementary DNA microarray. J. Vasc. Surg. 36, 379-385
47. Wang, Y., Wang, G.Z., Rabinovitch, P.S. and Tabas, I. (2014) Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-kappaB-mediated inflammation in macrophages. Circ. Res. 114, 421-433
48. McCormick, M.L., Gavrila, D. and Weintraub, N.L. (2007) Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 27, 461-469
49. Li, J.M. and Shah, A.M. (2003) Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J. Biol. Chem. 278, 12094-13100
50. Doughan, A.K., Harrison, D.G. and Dikalov, S.I. (2008) Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 102, 488-496
51. Leong, X.F., Mustafa, M.R., Das, S. and Jaarin, K. (2010) Association of elevated blood pressure and impaired vasorelaxation in experimental Sprague-Dawley rats fed with heated vegetable oil. Lipids Health Dis. 9, 66
52. Dikalova, A., Clempus, R., Lassegue, B., Cheng, G., McCoy, J., Dikalov, S., San Martin, A., Lyle, A., Weber, D.S., Weiss, D. et al. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112, 2668-2676
53. Weber, D.S., Rocic, P., Mellis, A.M., Laude, K., Lyle, A.N., Harrison, D.G. and Griendling, K.K. (2005) Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 288, H37-H42
54. Thomas, M., Gavrila, D., McCormick, M.L., Miller, Jr, F.J., Daugherty, A., Cassis, L.A., Dellsperger, K.C. and Weintraub, N.L. (2006) Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 114, 404-413
55. Gavazzi, G., Deffert, C., Trocme, C., Schappi, M., Herrmann, F.R. and Krause, K.H. (2007) NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension 50, 189-196
56. Kigawa, Y., Miyazaki, T., Lei, X.F., Nakamachi, T., Oguchi, T., Kim-Kaneyama, J.R., Taniyama, M., Tsunawaki, S., Shioda, S. and Miyazaki, A. (2014) NADPH oxidase deficiency exacerbates angiotensin II-induced abdominal aortic aneurysms in mice. Arterioscler. Thromb. Vasc. Biol. 34, 2413-2420
57. Johnston, W.F., Salmon, M., Su, G., Lu, G., Stone, M.L., Zhao, Y., Owens, G. K, Upchurch, Jr, G.R. and Ailawadi, G. (2013) Genetic and pharmacologic disruption of interleukin-1beta signaling inhibits experimental aortic aneurysm formation. Arterioscler. Thromb. Vasc. Biol. 33, 294-304
58. McNally, J.S., Davis, M.E., Giddens, D.P., Saha, A., Hwang, J., Dikalov, S., Jo, H. and Harrison, D.G. (2003) Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am. J. Physiol. Heart Circ. Physiol. 285, H2290-H2297
59. Pisoschi, A.M. and Pop, A. (2015) The role of antioxidants in the chemistry of oxidative stress: a review. Eur. J. Med. Chem. 97, 55-74
60. Zhang, Q., Huang, J.H., Xia, R.P., Duan, X.H., Jiang, Y.B., Jiang, Q. and Sun, W.J. (2011) Suppression of experimental abdominal aortic aneurysm in a rat model by the phosphodiesterase 3 inhibitor cilostazol. J. Surg. Res. 167, e385-e393
61. Schror, K. (2002) The pharmacology of cilostazol. Diabetes Obes. Metab. +4 (Suppl. 2), S14-S19
62. Brash, A.R. (1999) Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274, 23679-23682
63. Funk, C.D. (2006) Lipoxygenase pathways as mediators of early inflammatory events in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26, 1204-1206
64. Zuo, L., Christofi, F.L., Wright, V.P., Bao, S. and Clanton, T.L. (2004) Lipoxygenase-dependent superoxide release in skeletal muscle. J. Appl. Physiol. 97, 661-668
65. Liu, J.Y., Yang, J., Inceoglu, B., Qiu, H., Ulu, A., Hwang, S.H., Chiamvimonvat, N. and Hammock, B.D. (2010) Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. Biochem. Pharmacol. 79, 880-887
66. Zhao, L., Moos, M.P., Grabner, R., Pedrono, F., Fan, J., Kaiser, B., John, N., Schmidt, S., Spanbroek, R., Lötzer, K. et al. (2004) The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat. Med. 10, 966-973
67. Bhamidipati, C.M., Whatling, C.A., Mehta, G.S., Meher, A.K., Hajzus, V.A., Su, G., Salmon, M., Upchurch, Jr, G.R., Owens, G.K., Ailawadi, G. et al. (2014) 5-Lipoxygenase pathway in experimental abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 34, 2669-2678
68. Kristo, F., Hardy, G.J., Anderson, T.J., Sinha, S., Ahluwalia, N., Lin, A.Y., Passeri, J., Scherrer-Crosbie, M. and Gerszten, R.E. (2010) Pharmacological inhibition of BLT1 diminishes early abdominal aneurysm formation. Atherosclerosis 210, 107-113
69. Thompson, R.W. and Parks, W.C. (1996) Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann. N.Y. Acad. Sci. 800, 157-174
70. Yoshida, H., Yanai, H., Namiki, Y., Fukatsu-Sasaki, K., Furutani, N. and Tada, N. (2006) Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev. 12, 9-20
71. Morimoto, K., Hasegawa, T., Tanaka, A., Wulan, B., Yu, J., Morimoto, N., Okita, Y. and Okada, K. (2012) Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats. J. Vasc. Surg. 55, 1749-1758
72. Ahluwalia, N., Lin, A.Y., Tager, A.M., Pruitt, I.E., Anderson, T.J., Kristo, F., Shen, D., Cruz, A.R., Aikawa, M., Luster, A.D. and Gerszten, R.E. (2007) Inhibited aortic aneurysm formation in BLT1-deficient mice. J. Immunol. 179, 691-697
73. Cao, R.Y., Adams, M.A., Habenicht, A.J. and Funk, C.D. (2007) Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice. Prostaglandins Other Lipid Mediat. 84, 34-42
74. Di Gennaro, A., Wagsater, D., Mayranpaa, M.I., Gabrielsen, A., Swedenborg, J., Hamsten, A., Samuelsson, B., Eriksson, P. and Haeggström, J.Z. (2010) Increased expression of leukotriene C4 synthase and predominant formation of cysteinylleukotrienes in human abdominal aortic aneurysm. Proc. Natl. Acad. Sci. U.S.A. 107, 21093-21097
75. Houard, X., Ollivier, V., Louedec, L., Michel, J.B. and Back, M. (2009) Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus. FASEB J. 23, 1376-1383
76. Bisoendial, R.J., Tanck, M.W., Golledge, J., Broekhuizen, L.N., Legemate, D.A., Stroes, E.S. and Norman, P.E. (2012) The association between the gene encoding 5-lipoxygenase activating protein and abdominal aortic aneurysms. Atherosclerosis 220, 425-428
77. Dubois, R.N., Abramson, S.B., Crofford, L., Gupta, R.A., Simon, L.S., Van De Putte, L.B. and Lipsky, P.E. (1998) Cyclooxygenase in biology and disease. FASEB J. 12, 1063-1073
78. Reilly, J.M., Miralles, M., Wester, W.N. and Sicard, G.A. (1999) Differential expression of prostaglandin E2 and interleukin-6 in occlusive and aneurysmal aortic disease. Surgery 126, 624-627
79. Holmes, D.R., Wester, W., Thompson, R.W. and Reilly, J.M. (1997) Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms. J. Vasc. Surg. 25, 810-815
80. Walton, L.J., Franklin, I.J., Bayston, T., Brown, L.C., Greenhalgh, R.M., Taylor, G.W. and Powell, J.T. (1999) Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation 100, 48-54
81. Gitlin, J.M., Trivedi, D.B., Langenbach, R. and Loftin, C.D. (2007) Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice. Cardiovasc. Res. 73, 227-236
82. King, V.L., Trivedi, D.B., Gitlin, J.M. and Loftin, C.D. (2006) Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arterioscler. Thromb. Vasc. Biol. 26, 1137-1143
83. Cao, R.Y., St Amand, T., Li, X., Yoon, S.H., Wang, C.P., Song, H., Maruyama, T., Brown, P.M., Zelt, D.T. and Funk, C.D. (2012) Prostaglandin receptor EP4 in abdominal aortic aneurysms. Am. J. Pathol. 181, 313-321
84. Ghoshal, S. and Loftin, C.D. (2012) Cyclooxygenase-2 inhibition attenuates abdominal aortic aneurysm progression in hyperlipidemic mice. PLoS One 7, e44369
85. Mukherjee, K., Gitlin, J.M. and Loftin, C.D. (2012) Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotype. J. Cardiovasc. Pharmacol. 60, 520-529
86. Keeling, W.B., Hackmann, A.E., Colter, M.E., Stone, P.A., Johnson, B.L., Back, M.R., Bandyk, D.F. and Shames, M.L. (2007) MF-tricyclic inhibits growth of experimental abdominal aortic aneurysms. J. Surg. Res. 141, 192-195
87. Miralles, M., Wester, W., Sicard, G.A., Thompson, R. and Reilly, J.M. (1999) Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase. J. Vasc. Surg. 29, 884-892
88. Holmes, D.R., Petrinec, D., Wester, W., Thompson, R.W. and Reilly, J.M. (1996) Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. J. Surg. Res. 63, 305-309
89. Armstrong, P.J., Franklin, D.P., Carey, D.J. and Elmore, J.R. (2005) Suppression of experimental aortic aneurysms: comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors. Ann. Vasc. Surg. 19, 248-257
90. Kearney, P.M., Baigent, C., Godwin, J., Halls, H., Emberson, J.R. and Patrono, C. (2006) Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 332, 1302-1308
91. Antman, E.M., Bennett, J.S., Daugherty, A., Furberg, C., Roberts, H. and Taubert, K.A. (2007) Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 115, 1634-1642
92. Alderton, W.K., Cooper, C.E. and Knowles, R.G. (2001) Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357, 593-615
93. Stocker, R. and Keaney, Jr, J.F. (2004) Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381-1478
94. Gao, L., Siu, K.L., Chalupsky, K., Nguyen, A., Chen, P., Weintraub, N.L., Galis, Z. and Cai, H. (2012) Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid. Hypertension 59, 158-166
95. Siu, K.L., Miao, X.N. and Cai, H. (2014) Recoupling of eNOS with folic acid prevents abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E null mice. PLoS One 9, e88899
96. Kalyanasundaram, A., Elmore, J.R., Manazer, J.R., Golden, A., Franklin, D.P., Galt, S.W., Zakhary, E.M. and Carey, D.J. (2006) Simvastatin suppresses experimental aortic aneurysm expansion. J. Vasc. Surg. 43, 117-124
97. Steinmetz, E.F., Buckley, C., Shames, M.L., Ennis, T.L., Vanvickle-Chavez, S.J., Mao, D., Goeddel, L.A., Hawkins, C.J. and Thompson, RW. (2005) Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann. Surg. 241, 92-101
98. Schouten, O., van Laanen, J.H., Boersma, E., Vidakovic, R., Feringa, H.H., Dunkelgrun, M., Bax, J.J., Koning, J., van Urk, H. and Poldermans, D. (2006) Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur. J. Vasc. Endovasc. Surg. 32, 21-26
99. Sukhija, R., Aronow, W.S., Sandhu, R., Kakar, P. and Babu, S. (2006) Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am. J. Cardiol. 97, 279-280
100. Evans, J., Powell, J.T., Schwalbe, E., Loftus, I.M. and Thompson, M.M. (2007) Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur. J. Vasc. Endovasc. Surg. 34, 302-303
101. Zhang, Y., Naggar, J.C., Welzig, C.M., Beasley, D., Moulton, K.S., Park, H.J. and Galper, J.B. (2009) Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK. Arterioscler. Thromb. Vasc. Biol. 29, 1764-1771
102. Shiraya, S., Miyake, T., Aoki, M., Yoshikazu, F., Ohgi, S., Nishimura, M., Ogihara, T. and Morishita, R. (2009) Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration. Atherosclerosis 202, 34-40
103. Golledge, J., Cullen, B., Moran, C. and Rush, C. (2010) Efficacy of simvastatin in reducing aortic dilatation in mouse models of abdominal aortic aneurysm. Cardiovasc. Drugs Ther. 24, 373-378
104. Golledge, J., Cullen, B., Rush, C., Moran, C.S., Secomb, E., Wood, F., Daugherty, A., Campbell, J.H. and Norman, P.E. (2010) Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm. Atherosclerosis 210, 51-56
105. Krishna, S.M., Seto, S.W., Moxon, J.V., Rush, C., Walker, P.J., Norman, P.E. and Golledge, J. (2012) Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. Am. J. Pathol. 181, 706-718
106. Kuhlencordt, P.J., Gyurko, R., Han, F., Scherrer-Crosbie, M., Aretz, T.H., Hajjar, R., Picard, M.H. and Huang, P.L. (2001) Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104, 448-454
107. Miller, Jr, F.J. (2002) Aortic aneurysms: it's all about the stress. Arterioscler. Thromb. Vasc. Biol. 22, 1948-1949
108. Soares, M.P. and Bach, F.H. (2009) Heme oxygenase-1: from biology to therapeutic potential. Trends Mol. Med. 15, 50-58
109. Ryter, S.W., Alam, J. and Choi, A.M. (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86, 583-650
110. Schillinger, M., Exner, M., Mlekusch, W., Domanovits, H., Huber, K., Mannhalter, C., Wagner, O. and Minar, E. (2002) Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb. Res. 106, 131-136
111. Gregorek, A.C., Gornik, K.C., Polancec, D.S. and Dabelic, S. (2013) GT microsatellite repeats in the heme oxygenase-1 gene promoter associated with abdominal aortic aneurysm in Croatian patients. Biochem. Genet. 51, 482-492
112. Yamada, N., Yamaya, M., Okinaga, S., Nakayama, K., Sekizawa, K., Shibahara, S. and Sasaki, H. (2000) Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am. J. Hum. Genet. 66, 187-195
113. Nishiyama, A., Ohno, T., Iwata, S., Matsui, M., Hirota, K., Masutani, H., Nakamura, H. and Yodoi, J. (1999) Demonstration of the interaction of thioredoxin with p40phox, a phagocyte oxidase component, using a yeast two-hybrid system. Immunol. Lett. 68, 155-159
114. Billiet, L., Furman, C., Larigauderie, G., Copin, C., Brand, K., Fruchart, J.C. and Rouis, M. (2005) Extracellular human thioredoxin-1 inhibits lipopolysaccharide-induced interleukin-1beta expression in human monocyte-derived macrophages. J. Biol. Chem. 280, 40310-40318
115. Tamaki, H., Nakamura, H., Nishio, A., Nakase, H., Ueno, S., Uza, N., Kido, M., Inoue, S., Mikami, S. and Asada, M. (2006) Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology 131, 1110-1121
116. Yoshida, M., Korfhagen, T.R. and Whitsett, J.A. (2001) Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J. Immunol. 166, 7514-7519
117. Yang, H., Roberts, L.J., Shi, M.J., Zhou, L.C., Ballard, B.R., Richardson, A. and Guo, Z.M. (2004) Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ. Res. 95, 1075-1081
118. Ramos-Mozo, P., Madrigal-Matute, J., Martinez-Pinna, R., Blanco-Colio, L.M., Lopez, J.A., Camafeita, E., Meilhac, O., Michel, J.B., Aparicio, C. and Vega de Ceniga, M. (2011) Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: potential implication of oxidative stress in abdominal aortic aneurysm progression. Arterioscler. Thromb. Vasc. Biol. 31, 3011-3019
119. Parastatidis, I., Weiss, D., Joseph, G. and Taylor, W.R. (2013) Overexpression of catalase in vascular smooth muscle cells prevents the formation of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 33, 2389-2396
120. Sinha, I., Pearce, C.G., Cho, B.S., Hannawa, K.K., Roelofs, K.J., Stanley, J.C., Henke, P.K. and Upchurch, Jr, G.R. (2007) Differential regulation of the superoxide dismutase family in experimental aortic aneurysms and rat aortic explants. J. Surg. Res. 138, 156-162
121. Hao, Q., Chen, X., Wang, X., Dong, B. and Yang, C. (2014) Curcumin attenuates angiotensin II-induced abdominal aortic aneurysm by inhibition of inflammatory response and ERK signaling pathways. Evid. Based Complement. Alternat. Med. 2014, 270930
122. Piechota-Polanczyk, A., Goraca, A., Demyanets, S., Mittlboeck, M., Domenig, C., Neumayer, C., Wojta, J., Nanobachvili, J., Huk, I. and Klinger, M. (2012) Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-kappaB. Eur. J. Vasc. Endovasc. Surg. 44, 133-137
123. Watanabe, A., Ichiki, T., Sankoda, C., Takahara, Y., Ikeda, J., Inoue, E., Tokunou, T., Kitamoto, S. and Sunagawa, K. (2014) Suppression of abdominal aortic aneurysm formation by inhibition of prolyl hydroxylase domain protein through attenuation of inflammation and extracellular matrix disruption. Clin. Sci. 126, 671-678
124. Grigoryants, V., Hannawa, K.K., Pearce, C.G., Sinha, I., Roelofs, K.J., Ailawadi, G., Deatrick, K.B., Woodrum, D.T., Cho, B.S. and Henke, P. K (2005) Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. J. Vasc. Surg. 41, 108-114
125. Smith, J.V. and Luo, Y. (2004) Studies on molecular mechanisms of Ginkgo biloba extract. Appl. Microbiol. Biotechnol. 64, 465-472
126. Wang, L., Bai, Y., Wang, B., Cui, H., Wu, H., Lv, J.R., Mei, Y., Zhang, J.S., Liu, S., Qi, L.W. and Chen, Y. (2013) Suppression of experimental abdominal aortic aneurysms in the mice by treatment with Ginkgo biloba extract (EGb 761). J. Ethnopharmacol. 150, 308-315
127. Goel, A., Kunnumakkara, A.B. and Aggarwal, B.B. (2008) Curcumin as curecumin: from kitchen to clinic. Biochem. Pharmacol. 75, 787-809
128. Fan, J., Li, X., Yan, Y.W., Tian, X.H., Hou, W.J., Tong, H. and Bai, S.L. (2012) Curcumin attenuates rat thoracic aortic aneurysm formation by inhibition of the c-Jun N-terminal kinase pathway and apoptosis. Nutrition 28, 1068-1074
129. Parodi, F.E., Mao, D., Ennis, T.L., Pagano, M.B. and Thompson, R.W. (2006) Oral administration of diferuloylmethane (curcumin) suppresses proinflammatory cytokines and destructive connective tissue remodeling in experimental abdominal aortic aneurysms. Ann. Vasc. Surg. 20, 360-308
130. Fong, G.H. and Takeda, K. (2008) Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ. 15, 635-641
131. Dubey, R.K., Tyurina, Y.Y., Tyurin, V.A., Gillespie, D.G., Branch, R.A., Jackson, E.K. and Kagan, V.E. (1999) Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth. Circ. Res. 84, 229-239
132. Maiellaro-Rafferty, K., Weiss, D., Joseph, G., Wan, W., Gleason, R.L. and Taylor, W.R. (2011) Catalase overexpression in aortic smooth muscle prevents pathological mechanical changes underlying abdominal aortic aneurysm formation. Am. J. Physiol. Heart Circ. Physiol. 301, H355-H362
133. Singh, U., Devaraj, S. and Jialal, I. (2005) Vitamin E., oxidative stress, and inflammation. Annu. Rev. Nutr. 25, 151-174
134. Moat, S.J., Clarke, Z.L., Madhavan, A.K., Lewis, M.J. and Lang, D. (2006) Folic acid reverses endothelial dysfunction induced by inhibition of tetrahydrobiopterin biosynthesis. Eur. J. Pharmacol. 530, 250-258
135. Verhaar, M.C., Stroes, E. and Rabelink, T.J. (2002) Folates and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 22, 6-13
136. Daugherty, A. and Cassis, L.A. (2004) Mouse models of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 24, 429-434
137. Gopal, K., Nagarajan, P., Jedy, J., Raj, A.T., Gnanaselvi, S.K., Jahan, P., Sharma, Y., Shankar, E.M. and Kumar, J.M. (2013) β-Carotene attenuates angiotensin II-induced aortic aneurysm by alleviating macrophage recruitment in mice. PLoS One 8, e67098
138. Tornwall, M.E., Virtamo, J., Haukka, J.K., Albanes, D. and Huttunen, J.K. (2001) Alpha-tocopherol (vitamin E) and beta-carotene supplementation does not affect the risk for large abdominal aortic aneurysm in a controlled trial. Atherosclerosis 157, 167-173
139. May, J.M. (2000) How does ascorbic acid prevent endothelial dysfunction? Free Radic. Biol. Med. 28, 1421-1429
140. Tanaka, A., Hasegawa, T., Morimoto, K., Bao, W., Yu, J., Okita, Y., Tabata, Y. and Okada, K. (2014) Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm model. J. Vasc. Surg. 60, 749-758
141. Frankel, E.N., Waterhouse, A.L. and Kinsella, J.E. (1993) Inhibition of human LDL oxidation by resveratrol. Lancet 341, 1103-1104
142. Martinez, J. and Moreno, J.J. (2000) Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 59, 865-870
143. Orallo, F., Alvarez, E., Camina, M., Leiro, J.M., Gomez, E. and Fernandez, P. (2002) The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol. Pharmacol. 61, 294-302
144. Csiszar, A., Labinskyy, N., Podlutsky, A., Kaminski, P.M., Wolin, M.S., Zhang, C., Mukhopadhyay, P., Pacher, P., Hu, F. and de Cabo, R. (2008) Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am. J. Physiol. Heart Circ. Physiol. 294, H2721-H2735
145. Norata, G.D., Marchesi, P., Passamonti, S., Pirillo, A., Violi, F. and Catapano, A.L. (2007) Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis 191, 265-271
146. Brakenhielm, E., Cao, R. and Cao, Y. (2001) Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J. 15, 1798-1800
147. Palmieri, D., Pane, B., Barisione, C., Spinella, G., Garibaldi, S., Ghigliotti, G., Brunelli, C., Fulcheri, E. and Palombo, D. (2011) Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development. J. Surg. Res. 171, e237-e246
148. Perez-Vizcaino, F., Duarte, J. and Andriantsitohaina, R. (2006) Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic. Res. 40, 1054-1065
149. Wang, L., Wang, B., Li, H., Lu, H., Qiu, F., Xiong, L., Xu, Y., Wang, G., Liu, X., Wu, H. and Jing, H. (2012) Quercetin, a flavonoid with anti-inflammatory activity, suppresses the development of abdominal aortic aneurysms in mice. Eur. J. Pharmacol. 690, 133-141
150. Wang, L., Cheng, X., Li, H., Qiu, F., Yang, N., Wang, B., Lu, H., Wu, H., Shen, Y., Wang, Y. and Jing, H. (2014) Quercetin reduces oxidative stress and inhibits activation of cJun Nterminal kinase/activator protein1 signaling in an experimental mouse model of abdominal aortic aneurysm. Mol. Med. Rep. 9, 435-442
151. Golledge, J. and Norman, P.E. (2011) Current status of medical management for abdominal aortic aneurysm. Atherosclerosis 217, 57-63
152. Meijer, C.A., Stijnen, T., Wasser, M.N., Hamming, J.F., van Bockel, J.H. and Lindeman, J.H. (2013) Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial. Ann. Intern. Med. 159, 815-823
153. Sillesen, H., Eldrup, N., Hultgren, R., Lindeman, J., Bredahl, K., Thompson, M., Wanhainen, A., Wingren, U. and Swedenborg, J. (2015) Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm. Br. J. Surg. 102, 894-901